Xavier Marie Warot

Title: Xavier Marie Warot: Innovator in Benzimidazole Derivatives

Introduction

Xavier Marie Warot is a notable inventor based in Strasbourg, France. He has made significant contributions to the field of medicinal chemistry, particularly through his work on benzimidazole derivatives. His innovative approach has the potential to impact the treatment of various diseases.

Latest Patents

Warot holds a patent for novel benzimidazole derivatives, which are described by the formula (I) wherein Rto Rare is defined in the description and claims. These compounds are known to bind to Farnesoid-X-receptors (FXR) and can be utilized in treating diseases modulated by FXR agonists, such as diabetes and dyslipidemia. His patent represents a significant advancement in therapeutic options for these conditions. He has 1 patent to his name.

Career Highlights

Warot is currently associated with Hoffmann-La Roche Inc., a leading global healthcare company. His work at the company has allowed him to focus on innovative solutions in drug development. His expertise in medicinal chemistry has been instrumental in advancing the company's research initiatives.

Collaborations

Throughout his career, Warot has collaborated with esteemed colleagues, including Gregory Martin Benson and Konrad H. Bleicher. These collaborations have fostered a productive environment for innovation and research.

Conclusion

Xavier Marie Warot is a distinguished inventor whose work on benzimidazole derivatives holds promise for the treatment of significant health issues. His contributions to medicinal chemistry continue to pave the way for future advancements in the field.